human nk cell isolation kit Search Results


97
Miltenyi Biotec negative selection kit
Negative Selection Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/NK+Cell+Isolation+Kit%2C+human/pmc12932519-44-6-14
Average 97 stars, based on 1 article reviews
negative selection kit - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

91
R&D Systems magcellect human nk cell isolation kit
Magcellect Human Nk Cell Isolation Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/MagCellect+Human+NK+Cell+Isolation+Kit/pmc04975565-41-72-78
Average 91 stars, based on 1 article reviews
magcellect human nk cell isolation kit - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

94
Miltenyi Biotec macsxpress whole blood nk cell isolation kit
The three natural killer-cell-mediated tumour defense mechanisms. The first mechanism is degranulation with fast kinetics and a directed (cell–cell-contact-mediated) mechanism (A). The second mechanism is the induction of the cytokine-induced death receptor pathway (B). This mechanism is not directed (no cell–cell contact is required) and is promoted by TNF-α and IFN-γ and inhibited by IL-6. The third mechanism is extracellular-vesicle/exosome-mediated tumour defense which is not directed (C). Vesicles containing enzymes such as perforin and granzyme are released by NK cells and may induce distant, not directed target cell apoptosis. The experimental setup of this study is displayed in D and E. The <t>natural</t> <t>killer</t> <t>cell</t> line NK92 was treated with 2.2% sevoflurane for 2 hr. In most experiments, NK92 cells were co-incubated with leukemia cells (K562) as a target cell line for varying durations (between 0 and 48 hr); for the perforin measurements in the NK-cell supernatant and NK-cell cytoplasm, no co-incubation was performed. NK = natural killer; IL-6 = interleukin-6; IFN-γ = interferon-gamma; TNF-α = tumour necrosis factor-alpha; mRNA = messenger RNA
Macsxpress Whole Blood Nk Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/MACSxpress+Whole+Blood+NK+Cell+Isolation+Kit%2C+human/pmc13275609-36-9-17
Average 94 stars, based on 1 article reviews
macsxpress whole blood nk cell isolation kit - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec human cd56 cd16 nk cell isolation kit
The three natural killer-cell-mediated tumour defense mechanisms. The first mechanism is degranulation with fast kinetics and a directed (cell–cell-contact-mediated) mechanism (A). The second mechanism is the induction of the cytokine-induced death receptor pathway (B). This mechanism is not directed (no cell–cell contact is required) and is promoted by TNF-α and IFN-γ and inhibited by IL-6. The third mechanism is extracellular-vesicle/exosome-mediated tumour defense which is not directed (C). Vesicles containing enzymes such as perforin and granzyme are released by NK cells and may induce distant, not directed target cell apoptosis. The experimental setup of this study is displayed in D and E. The <t>natural</t> <t>killer</t> <t>cell</t> line NK92 was treated with 2.2% sevoflurane for 2 hr. In most experiments, NK92 cells were co-incubated with leukemia cells (K562) as a target cell line for varying durations (between 0 and 48 hr); for the perforin measurements in the NK-cell supernatant and NK-cell cytoplasm, no co-incubation was performed. NK = natural killer; IL-6 = interleukin-6; IFN-γ = interferon-gamma; TNF-α = tumour necrosis factor-alpha; mRNA = messenger RNA
Human Cd56 Cd16 Nk Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/CD56%2BCD16-+NK+Cell+Isolation+Kit%2C+human/pm35222389-64-18-26
Average 93 stars, based on 1 article reviews
human cd56 cd16 nk cell isolation kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Miltenyi Biotec nk cells
The three natural killer-cell-mediated tumour defense mechanisms. The first mechanism is degranulation with fast kinetics and a directed (cell–cell-contact-mediated) mechanism (A). The second mechanism is the induction of the cytokine-induced death receptor pathway (B). This mechanism is not directed (no cell–cell contact is required) and is promoted by TNF-α and IFN-γ and inhibited by IL-6. The third mechanism is extracellular-vesicle/exosome-mediated tumour defense which is not directed (C). Vesicles containing enzymes such as perforin and granzyme are released by NK cells and may induce distant, not directed target cell apoptosis. The experimental setup of this study is displayed in D and E. The <t>natural</t> <t>killer</t> <t>cell</t> line NK92 was treated with 2.2% sevoflurane for 2 hr. In most experiments, NK92 cells were co-incubated with leukemia cells (K562) as a target cell line for varying durations (between 0 and 48 hr); for the perforin measurements in the NK-cell supernatant and NK-cell cytoplasm, no co-incubation was performed. NK = natural killer; IL-6 = interleukin-6; IFN-γ = interferon-gamma; TNF-α = tumour necrosis factor-alpha; mRNA = messenger RNA
Nk Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/CD56%2BCD16%2B+NK+Cell+Isolation+Kit%2C+human/pmc07320583-112-0-7
Average 90 stars, based on 1 article reviews
nk cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human nk cell isolation kit #17955
The three natural killer-cell-mediated tumour defense mechanisms. The first mechanism is degranulation with fast kinetics and a directed (cell–cell-contact-mediated) mechanism (A). The second mechanism is the induction of the cytokine-induced death receptor pathway (B). This mechanism is not directed (no cell–cell contact is required) and is promoted by TNF-α and IFN-γ and inhibited by IL-6. The third mechanism is extracellular-vesicle/exosome-mediated tumour defense which is not directed (C). Vesicles containing enzymes such as perforin and granzyme are released by NK cells and may induce distant, not directed target cell apoptosis. The experimental setup of this study is displayed in D and E. The <t>natural</t> <t>killer</t> <t>cell</t> line NK92 was treated with 2.2% sevoflurane for 2 hr. In most experiments, NK92 cells were co-incubated with leukemia cells (K562) as a target cell line for varying durations (between 0 and 48 hr); for the perforin measurements in the NK-cell supernatant and NK-cell cytoplasm, no co-incubation was performed. NK = natural killer; IL-6 = interleukin-6; IFN-γ = interferon-gamma; TNF-α = tumour necrosis factor-alpha; mRNA = messenger RNA
Human Nk Cell Isolation Kit #17955, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/human+nk+cell+isolation+kit++17955/pmc08831943-77-7-13
Average 90 stars, based on 1 article reviews
human nk cell isolation kit #17955 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human negative selection-based nk cell isolation kit easysep-19615
Blocking the membranal-PCNA on MM cell lines enhances IFN-γ secretion and degranulation of <t>NK</t> <t>cells.</t> ( A ) Primary NK cells from a healthy donor were incubated with U266 cell lines and mAb 14-25-9 or mIgG1 for 18 h using different ratios of effector:target (1:1 and 1:3). IFN-γ was measured by ELISA. ( B ) Primary NK cells from a healthy donor were incubated either with RPMI 8226 or U266 cell lines and mAb 14-25-9 or mIgG1 for 5 h. Surface CD107a was measured by flow cytometry, to detect NK cells that had degranulated. Mouse IgG1 acts as a background control (red bars) in comparison to mAb 14-25-9 (blue bars). Dead cells were discriminated against using 7-AAD. Data is shown from three independent replicates and the experiment was repeated three times. Two-way ANOVA test showed p ** < 0.01 and p *** < 0.001. Statistical analysis and design were performed using Prism GraphPad v8 (California).
Human Negative Selection Based Nk Cell Isolation Kit Easysep 19615, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/human+negative+selection+based+nk+cell+isolation+kit+easysep+19615/pmc09105815-110-6-13
Average 90 stars, based on 1 article reviews
human negative selection-based nk cell isolation kit easysep-19615 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc negative selection kit easysep human nk cell enrichment kit ii
Type I IFN subtypes modulate <t>natural</t> <t>killer</t> <t>cells</t> in-vitro . Changes (presented as deltaΔ) in (A) activation measured by CD69+ expression on <t>NK</t> <t>cells,</t> and in (B) degranulation measured by CD107a+ expression on NK cells. Representative dot plots are shown on right side for CD69+ (A) and CD107a+ (B) expression on NK cells. PBMCs were stimulated with respective Type I IFN subtypes for 4h followed by a degranulation assay for 5h with K562 cell line. Plotted percentage delta values were calculated by subtracting the corresponding unstimulated condition with K562 cell co-cultures from each experiment. (C) Spearman correlation coefficient (r) between delta changes in activation (CD69) and delta changes in degranulation (CD107a) of NK cells after IFN-stimulation. Paired t test; non parametric Wilcoxon test; n=10. Spearman correlation; 100 XY pairs. *p<0.05; **p<0.005.
Negative Selection Kit Easysep Human Nk Cell Enrichment Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nk+cell+isolation+kit/negative+selection+kits+stemcell+easysep+human+nk+cell+isolation+kit/pmc10757368-24-7-20
Average 90 stars, based on 1 article reviews
negative selection kit easysep human nk cell enrichment kit ii - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

N/A
Isolation of human CD56+CD8+ NK cells and CD56+CD8- NK cells
  Buy from Supplier

N/A
Untouched isolation of NK cells directly from LRSC
  Buy from Supplier

N/A
Untouched isolation of NK cells directly from buffy coats
  Buy from Supplier

Image Search Results


The three natural killer-cell-mediated tumour defense mechanisms. The first mechanism is degranulation with fast kinetics and a directed (cell–cell-contact-mediated) mechanism (A). The second mechanism is the induction of the cytokine-induced death receptor pathway (B). This mechanism is not directed (no cell–cell contact is required) and is promoted by TNF-α and IFN-γ and inhibited by IL-6. The third mechanism is extracellular-vesicle/exosome-mediated tumour defense which is not directed (C). Vesicles containing enzymes such as perforin and granzyme are released by NK cells and may induce distant, not directed target cell apoptosis. The experimental setup of this study is displayed in D and E. The natural killer cell line NK92 was treated with 2.2% sevoflurane for 2 hr. In most experiments, NK92 cells were co-incubated with leukemia cells (K562) as a target cell line for varying durations (between 0 and 48 hr); for the perforin measurements in the NK-cell supernatant and NK-cell cytoplasm, no co-incubation was performed. NK = natural killer; IL-6 = interleukin-6; IFN-γ = interferon-gamma; TNF-α = tumour necrosis factor-alpha; mRNA = messenger RNA

Journal: Canadian Journal of Anaesthesia

Article Title: Effects of sevoflurane on natural killer cell-induced apoptosis of malignant tumour cells: an in vitro laboratory study

doi: 10.1007/s12630-026-03129-z

Figure Lengend Snippet: The three natural killer-cell-mediated tumour defense mechanisms. The first mechanism is degranulation with fast kinetics and a directed (cell–cell-contact-mediated) mechanism (A). The second mechanism is the induction of the cytokine-induced death receptor pathway (B). This mechanism is not directed (no cell–cell contact is required) and is promoted by TNF-α and IFN-γ and inhibited by IL-6. The third mechanism is extracellular-vesicle/exosome-mediated tumour defense which is not directed (C). Vesicles containing enzymes such as perforin and granzyme are released by NK cells and may induce distant, not directed target cell apoptosis. The experimental setup of this study is displayed in D and E. The natural killer cell line NK92 was treated with 2.2% sevoflurane for 2 hr. In most experiments, NK92 cells were co-incubated with leukemia cells (K562) as a target cell line for varying durations (between 0 and 48 hr); for the perforin measurements in the NK-cell supernatant and NK-cell cytoplasm, no co-incubation was performed. NK = natural killer; IL-6 = interleukin-6; IFN-γ = interferon-gamma; TNF-α = tumour necrosis factor-alpha; mRNA = messenger RNA

Article Snippet: Magnetic purification of NK cells was performed using the MACSxpress® Whole Blood NK Cell Isolation Kit, human (Miltenyi Biotech, Bergisch Gladbach, Germany).

Techniques: Incubation

Sevoflurane did not affect natural killer cell viability. Live NK92 cells are defined as Annexin V− and FVS660− cells, determined by flow cytometry analysis. NK92 cells were exposed for 2 hr to sevoflurane (or to air only), followed by a short incubation phase of 1, 2, 4, and 6 hr (A), and a long one of 24 and 48 hr (B). All measurements in Fig. 2 were analyzed using two-way analysis of variance, and multiple comparisons were corrected using the Bonferroni method (four comparisons in A and three comparisons in B). Values represent means (standard deviations). Six independent experiments were included in this analysis. FVS = Fixable Viability Stain; NK = natural killer; Sevo = sevoflurane

Journal: Canadian Journal of Anaesthesia

Article Title: Effects of sevoflurane on natural killer cell-induced apoptosis of malignant tumour cells: an in vitro laboratory study

doi: 10.1007/s12630-026-03129-z

Figure Lengend Snippet: Sevoflurane did not affect natural killer cell viability. Live NK92 cells are defined as Annexin V− and FVS660− cells, determined by flow cytometry analysis. NK92 cells were exposed for 2 hr to sevoflurane (or to air only), followed by a short incubation phase of 1, 2, 4, and 6 hr (A), and a long one of 24 and 48 hr (B). All measurements in Fig. 2 were analyzed using two-way analysis of variance, and multiple comparisons were corrected using the Bonferroni method (four comparisons in A and three comparisons in B). Values represent means (standard deviations). Six independent experiments were included in this analysis. FVS = Fixable Viability Stain; NK = natural killer; Sevo = sevoflurane

Article Snippet: Magnetic purification of NK cells was performed using the MACSxpress® Whole Blood NK Cell Isolation Kit, human (Miltenyi Biotech, Bergisch Gladbach, Germany).

Techniques: Flow Cytometry, Incubation, Staining

Sevoflurane did not affect natural killer cell degranulation, cytokine messenger ribonucleic acid induction, or the quantity of released extracellular vesicles. NK92 cell degranulation (A) was assessed by the release of CD107a (a marker of degranulation, analyzed by flow cytometry) and induction of IFN-γ (B), TNF-α (C), and IL-6 (D) mRNA (analyzed by real-time polymerase chain reaction) were quantified in NK92 cells with (sevoflurane [sevo]) or without (air) exposure to sevo and incubation with K562 tumour cells. Control cells (ctrl) were not exposed to tumour cells, and the positive degranulation control was NK92 cells stimulated (pos) with PMA and ionomycin. Ribonucleic acid data were normalized. The size (E) and number (F) of EVs released by NK92 cells with (sevo) and without (air) exposure to sevoflurane was quantified by nanotracking analysis. Particles were collected at 48 hr. An unpaired, two-sided Student’s t test was used to compare the air and sevoflurane groups (Fig. 4A–F). Bar graphs show means (standard deviations); box plots illustrate the median [interquartile range], and whiskers indicate min/max values. A minimum of three independent experiments were included in each of the analyses. CD = cluster of differentiation; Ctrl = negative control; IFN-γ = interferon-gamma; IL-6 = interleukin-6; mRNA = messenger ribonucleic acid; NK = natural killer; Pos = positive control; PMA = phorbol 12-myristate 13-acetate; Sevo = sevoflurane; TNF-α = tumour necrosis factor-alpha

Journal: Canadian Journal of Anaesthesia

Article Title: Effects of sevoflurane on natural killer cell-induced apoptosis of malignant tumour cells: an in vitro laboratory study

doi: 10.1007/s12630-026-03129-z

Figure Lengend Snippet: Sevoflurane did not affect natural killer cell degranulation, cytokine messenger ribonucleic acid induction, or the quantity of released extracellular vesicles. NK92 cell degranulation (A) was assessed by the release of CD107a (a marker of degranulation, analyzed by flow cytometry) and induction of IFN-γ (B), TNF-α (C), and IL-6 (D) mRNA (analyzed by real-time polymerase chain reaction) were quantified in NK92 cells with (sevoflurane [sevo]) or without (air) exposure to sevo and incubation with K562 tumour cells. Control cells (ctrl) were not exposed to tumour cells, and the positive degranulation control was NK92 cells stimulated (pos) with PMA and ionomycin. Ribonucleic acid data were normalized. The size (E) and number (F) of EVs released by NK92 cells with (sevo) and without (air) exposure to sevoflurane was quantified by nanotracking analysis. Particles were collected at 48 hr. An unpaired, two-sided Student’s t test was used to compare the air and sevoflurane groups (Fig. 4A–F). Bar graphs show means (standard deviations); box plots illustrate the median [interquartile range], and whiskers indicate min/max values. A minimum of three independent experiments were included in each of the analyses. CD = cluster of differentiation; Ctrl = negative control; IFN-γ = interferon-gamma; IL-6 = interleukin-6; mRNA = messenger ribonucleic acid; NK = natural killer; Pos = positive control; PMA = phorbol 12-myristate 13-acetate; Sevo = sevoflurane; TNF-α = tumour necrosis factor-alpha

Article Snippet: Magnetic purification of NK cells was performed using the MACSxpress® Whole Blood NK Cell Isolation Kit, human (Miltenyi Biotech, Bergisch Gladbach, Germany).

Techniques: Marker, Flow Cytometry, Real-time Polymerase Chain Reaction, Incubation, Control, Negative Control, Positive Control

Blocking the membranal-PCNA on MM cell lines enhances IFN-γ secretion and degranulation of NK cells. ( A ) Primary NK cells from a healthy donor were incubated with U266 cell lines and mAb 14-25-9 or mIgG1 for 18 h using different ratios of effector:target (1:1 and 1:3). IFN-γ was measured by ELISA. ( B ) Primary NK cells from a healthy donor were incubated either with RPMI 8226 or U266 cell lines and mAb 14-25-9 or mIgG1 for 5 h. Surface CD107a was measured by flow cytometry, to detect NK cells that had degranulated. Mouse IgG1 acts as a background control (red bars) in comparison to mAb 14-25-9 (blue bars). Dead cells were discriminated against using 7-AAD. Data is shown from three independent replicates and the experiment was repeated three times. Two-way ANOVA test showed p ** < 0.01 and p *** < 0.001. Statistical analysis and design were performed using Prism GraphPad v8 (California).

Journal: International Journal of Molecular Sciences

Article Title: Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma

doi: 10.3390/ijms23094717

Figure Lengend Snippet: Blocking the membranal-PCNA on MM cell lines enhances IFN-γ secretion and degranulation of NK cells. ( A ) Primary NK cells from a healthy donor were incubated with U266 cell lines and mAb 14-25-9 or mIgG1 for 18 h using different ratios of effector:target (1:1 and 1:3). IFN-γ was measured by ELISA. ( B ) Primary NK cells from a healthy donor were incubated either with RPMI 8226 or U266 cell lines and mAb 14-25-9 or mIgG1 for 5 h. Surface CD107a was measured by flow cytometry, to detect NK cells that had degranulated. Mouse IgG1 acts as a background control (red bars) in comparison to mAb 14-25-9 (blue bars). Dead cells were discriminated against using 7-AAD. Data is shown from three independent replicates and the experiment was repeated three times. Two-way ANOVA test showed p ** < 0.01 and p *** < 0.001. Statistical analysis and design were performed using Prism GraphPad v8 (California).

Article Snippet: Cells were isolated using a human negative selection-based NK cell isolation kit (EasySep-19615, STEMCELL).

Techniques: Blocking Assay, Incubation, Enzyme-linked Immunosorbent Assay, Flow Cytometry, Control, Comparison

Blocking the membranal-PCNA on primary BM mononuclear cells from MM patients enhanced the activation of NK cells. ( A ) NKp44 isoform 1-transduced NK92 cells (NK92-44-1) were incubated either with Pat#MM2 or Pat#MM7 primary cells for 18 h. ( B ) Primary NK cells from a healthy donor were incubated either with Pat#MM2 or Pat#MM7 primary cells for 18 h. ( C ) Primary NK cells from another unrelated healthy donor were incubated either with Pat#MM3.1 or Pat#MM4.1 primary cells for 18 h. Mouse IgG1 was used as a background control (red bars) for mAb 14-25-9 (blue bars). IFN-γ was measured by ELISA. Data is shown of three technical replicates. Two-way ANOVA test showed p * < 0.05, p ** < 0.01, and p *** < 0.001. Statistical analysis and design were performed using Prism GraphPad v8.

Journal: International Journal of Molecular Sciences

Article Title: Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma

doi: 10.3390/ijms23094717

Figure Lengend Snippet: Blocking the membranal-PCNA on primary BM mononuclear cells from MM patients enhanced the activation of NK cells. ( A ) NKp44 isoform 1-transduced NK92 cells (NK92-44-1) were incubated either with Pat#MM2 or Pat#MM7 primary cells for 18 h. ( B ) Primary NK cells from a healthy donor were incubated either with Pat#MM2 or Pat#MM7 primary cells for 18 h. ( C ) Primary NK cells from another unrelated healthy donor were incubated either with Pat#MM3.1 or Pat#MM4.1 primary cells for 18 h. Mouse IgG1 was used as a background control (red bars) for mAb 14-25-9 (blue bars). IFN-γ was measured by ELISA. Data is shown of three technical replicates. Two-way ANOVA test showed p * < 0.05, p ** < 0.01, and p *** < 0.001. Statistical analysis and design were performed using Prism GraphPad v8.

Article Snippet: Cells were isolated using a human negative selection-based NK cell isolation kit (EasySep-19615, STEMCELL).

Techniques: Blocking Assay, Activation Assay, Incubation, Control, Enzyme-linked Immunosorbent Assay

Type I IFN subtypes modulate natural killer cells in-vitro . Changes (presented as deltaΔ) in (A) activation measured by CD69+ expression on NK cells, and in (B) degranulation measured by CD107a+ expression on NK cells. Representative dot plots are shown on right side for CD69+ (A) and CD107a+ (B) expression on NK cells. PBMCs were stimulated with respective Type I IFN subtypes for 4h followed by a degranulation assay for 5h with K562 cell line. Plotted percentage delta values were calculated by subtracting the corresponding unstimulated condition with K562 cell co-cultures from each experiment. (C) Spearman correlation coefficient (r) between delta changes in activation (CD69) and delta changes in degranulation (CD107a) of NK cells after IFN-stimulation. Paired t test; non parametric Wilcoxon test; n=10. Spearman correlation; 100 XY pairs. *p<0.05; **p<0.005.

Journal: Frontiers in Immunology

Article Title: Sex-dependent differences in type I IFN-induced natural killer cell activation

doi: 10.3389/fimmu.2023.1277967

Figure Lengend Snippet: Type I IFN subtypes modulate natural killer cells in-vitro . Changes (presented as deltaΔ) in (A) activation measured by CD69+ expression on NK cells, and in (B) degranulation measured by CD107a+ expression on NK cells. Representative dot plots are shown on right side for CD69+ (A) and CD107a+ (B) expression on NK cells. PBMCs were stimulated with respective Type I IFN subtypes for 4h followed by a degranulation assay for 5h with K562 cell line. Plotted percentage delta values were calculated by subtracting the corresponding unstimulated condition with K562 cell co-cultures from each experiment. (C) Spearman correlation coefficient (r) between delta changes in activation (CD69) and delta changes in degranulation (CD107a) of NK cells after IFN-stimulation. Paired t test; non parametric Wilcoxon test; n=10. Spearman correlation; 100 XY pairs. *p<0.05; **p<0.005.

Article Snippet: NK cells were isolated from PBMCs using negative selection kit EasySep human NK cell enrichment kit II (Catalog no. 19055, StemCell Technologies).

Techniques: In Vitro, Activation Assay, Expressing, Degranulation Assay

Sex differences in NK cell activation after TLR7/8 stimulation. (A, B) Poly-IFNα ELISA quantification of supernatants after overnight stimulation with 1ug/mL TLR7/8 agonist (CL097) of male and female-derived PBMCs (A) and pDCs (B) . Average of duplicates are represented in box and whisker plots, n=13 (A) and n=12 (B) . Mann-Whitney test. (C) Representation of transwell co-culture system. Overnight culture of NK cells, plated in upper chamber, with stimulated or unstimulated PBMCs or pDCs, plated in lower chamber. Image created with BioRender.com . (D, E) Relative activation levels measured by CD69+ NK cells normalized to their corresponding control condition (untreated). NK cells were cultured with control stimulation, as well as co-cultured with unstimulated or stimulated (CL097) PBMCs (D) or pDCs (E) from male and female donors in transwell system. Total of 16 independent donors in (D) or 12 independent donors in (E) , consisting of equal numbers of male and female donors. Absolute expression levels relative to untreated condition. Paired sets of a male- and female-donors were matched for each experiment including controls. Wilcoxon test paired (solid line); 2way ANOVA test (dotted line); *p<0.05**; p<0.005; ***p<0.0005; ****p<0.00005.

Journal: Frontiers in Immunology

Article Title: Sex-dependent differences in type I IFN-induced natural killer cell activation

doi: 10.3389/fimmu.2023.1277967

Figure Lengend Snippet: Sex differences in NK cell activation after TLR7/8 stimulation. (A, B) Poly-IFNα ELISA quantification of supernatants after overnight stimulation with 1ug/mL TLR7/8 agonist (CL097) of male and female-derived PBMCs (A) and pDCs (B) . Average of duplicates are represented in box and whisker plots, n=13 (A) and n=12 (B) . Mann-Whitney test. (C) Representation of transwell co-culture system. Overnight culture of NK cells, plated in upper chamber, with stimulated or unstimulated PBMCs or pDCs, plated in lower chamber. Image created with BioRender.com . (D, E) Relative activation levels measured by CD69+ NK cells normalized to their corresponding control condition (untreated). NK cells were cultured with control stimulation, as well as co-cultured with unstimulated or stimulated (CL097) PBMCs (D) or pDCs (E) from male and female donors in transwell system. Total of 16 independent donors in (D) or 12 independent donors in (E) , consisting of equal numbers of male and female donors. Absolute expression levels relative to untreated condition. Paired sets of a male- and female-donors were matched for each experiment including controls. Wilcoxon test paired (solid line); 2way ANOVA test (dotted line); *p<0.05**; p<0.005; ***p<0.0005; ****p<0.00005.

Article Snippet: NK cells were isolated from PBMCs using negative selection kit EasySep human NK cell enrichment kit II (Catalog no. 19055, StemCell Technologies).

Techniques: Activation Assay, Enzyme-linked Immunosorbent Assay, Derivative Assay, Whisker Assay, MANN-WHITNEY, Co-Culture Assay, Control, Cell Culture, Expressing

NK cell-intrinsic sex differences in response to TLR7/8 stimulation. (A, B) Relative activation of CD69+ NK cells, separated by sex, after overnight cultures with control stimulations, as well as co-cultures with unstimulated and CL097-stimulated PBMCs (A) or pDCs (B) in transwell system. Activation levels were relativized to their own control condition (untreated). (C, D) Relative activation levels measured by CD69+ NK cells by further separating the sex of NK cells- and PBMCs-derived donors (C) or pDCs-derived donors (D) . Activation levels were relativized to their own control condition (untreated). Total of 16 independent donors in (D) or 12 independent donors in (E) , consisting of equal number of male and female donors. Paired sets of a male- and female-donors were matched for each experiment, including controls. Male NK cells (yellow); female NK cells (turquoise). Wilcoxon test paired (solid line); 2way ANOVA test (dotted line); ns, non-significant; *p<0.05; **p<0.005; ***p<0.0005; ****p<0.00005.

Journal: Frontiers in Immunology

Article Title: Sex-dependent differences in type I IFN-induced natural killer cell activation

doi: 10.3389/fimmu.2023.1277967

Figure Lengend Snippet: NK cell-intrinsic sex differences in response to TLR7/8 stimulation. (A, B) Relative activation of CD69+ NK cells, separated by sex, after overnight cultures with control stimulations, as well as co-cultures with unstimulated and CL097-stimulated PBMCs (A) or pDCs (B) in transwell system. Activation levels were relativized to their own control condition (untreated). (C, D) Relative activation levels measured by CD69+ NK cells by further separating the sex of NK cells- and PBMCs-derived donors (C) or pDCs-derived donors (D) . Activation levels were relativized to their own control condition (untreated). Total of 16 independent donors in (D) or 12 independent donors in (E) , consisting of equal number of male and female donors. Paired sets of a male- and female-donors were matched for each experiment, including controls. Male NK cells (yellow); female NK cells (turquoise). Wilcoxon test paired (solid line); 2way ANOVA test (dotted line); ns, non-significant; *p<0.05; **p<0.005; ***p<0.0005; ****p<0.00005.

Article Snippet: NK cells were isolated from PBMCs using negative selection kit EasySep human NK cell enrichment kit II (Catalog no. 19055, StemCell Technologies).

Techniques: Activation Assay, Control, Derivative Assay